October 15, 2015
Since 2013 a new series of medications has offered patients with hepatitis C something radical – a 90 to 99 percent cure rate.
October 14, 2015
A bipartisan group of 20 United States senators have a message for the Centers for Medicare and Medicaid Services: Wait to finalize reimbursement coding policy for biosimilars.
October 13, 2015
Immuno-oncology therapies engage the body’s immune system in fighting off cancer, offering some patients unprecedented results.
October 8, 2015
A new initiative has an important message for pain patients: Every second counts after accidental opioid overdoses, so be prepared.
October 6, 2015
Infectious diseases can pose a threat to all infants, but particularly those born prematurely.
October 1, 2015
Pediatric populations historically suffer from a dearth of medical therapies; few new medications are tested on and approved specifically for infants and young children.
October 1, 2015
By Alan Marks, MD, and Mary Ann Chapman, PhD Despite major advances in cancer medicine (oncology), cancer remains a deadly…
September 29, 2015
Screening questionnaires offers a simple, inexpensive way to proactively identify and educate patients at risk for COPD (chronic obstructive pulmonary disease).
September 24, 2015
J-Codes, the billing codes used for medical therapies and procedures, could impact how well physicians and health care systems can monitor patient responses to biological medicines as more biosimilars enter the U.S. market.
September 23, 2015
The Centers for Disease Control and Prevention has drafted new guidelines on prescribing opioids for chronic pain—and they could be bad news for patients living with pain.
